Bafna Pharmaceuticals Limited — Others, 29-06-2025: Disclosure under SEBI Takeover Regulations

Bafna Pharmaceuticals has submitted its annual disclosure of shareholding from promoters for the year ended March 31, 2025. This update confirms the current substantial ownership held by the promoters, reflecting their continuing control and confidence in the company. The disclosure is relevant for shareholders as it provides transparency on promoter stakes and helps assess potential influence on company decisions.